Announcement of Analytical Validation for SPOT-MAS on Five Cancers Lacking Standard Screening (LSS)

We previously developed a SPOT-MAS assay to capture ctDNA signatures from 05 common cancer types (breast, lung, liver, colorectal, and stomach) and successfully facilitated early-stage detection in both retrospective (1)